Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $425.00

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by Evercore ISI from $385.00 to $425.00 in a research report report published on Tuesday morning, Benzinga reports. The firm currently has an in-line rating on the medical equipment provider’s stock.

Several other research analysts have also recently issued reports on ISRG. Stifel Nicolaus increased their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a buy rating in a research note on Monday, April 8th. Piper Sandler upped their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the company an overweight rating in a report on Friday, April 19th. The Goldman Sachs Group initiated coverage on Intuitive Surgical in a report on Thursday, May 30th. They set a buy rating and a $500.00 target price on the stock. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a hold rating in a report on Friday, April 19th. Finally, BTIG Research raised their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a buy rating in a report on Friday, April 19th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of Moderate Buy and an average price target of $404.79.

Intuitive Surgical Trading Down 0.9 %

Shares of Intuitive Surgical stock opened at $434.81 on Tuesday. The stock has a market capitalization of $154.23 billion, a P/E ratio of 78.49, a PEG ratio of 5.67 and a beta of 1.39. The business’s fifty day moving average price is $407.60 and its 200 day moving average price is $385.43. Intuitive Surgical has a twelve month low of $254.85 and a twelve month high of $448.10.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the prior year, the company posted $1.00 EPS. The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. As a group, sell-side analysts predict that Intuitive Surgical will post 4.8 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 175 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the sale, the senior vice president now owns 883 shares of the company’s stock, valued at $343,628.28. The disclosure for this sale can be found here. Insiders sold a total of 17,956 shares of company stock valued at $6,927,011 in the last quarter. 0.80% of the stock is currently owned by insiders.

Institutional Trading of Intuitive Surgical

Large investors have recently modified their holdings of the stock. Norges Bank bought a new position in Intuitive Surgical in the fourth quarter valued at about $1,313,238,000. WCM Investment Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $575,536,000. Capital Research Global Investors bought a new position in Intuitive Surgical during the 1st quarter worth $374,390,000. International Assets Investment Management LLC lifted its holdings in Intuitive Surgical by 32,360.5% during the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock worth $231,721,000 after buying an additional 684,749 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in shares of Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after buying an additional 678,375 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.